Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum-Reference-Cited by-同舟云学术

Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum

Published:2005-09-08 Issue:5 Volume:118 Page:1234-1240
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Steuber Thomas,Vickers Andrew J.,Haese Alexander,Becker Charlotte,Pettersson Kim,Chun Felix K.-H.,Kattan Michael W.,Eastham James A.,Scardino Peter T.,Huland Hartwig,Lilja Hans

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Cancer control with radical prostatectomy alone in 1,000 consecutive patients;Hull;J Urol,2002

2. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

3. Results of radical prostatectomy in men with clinically localized prostate cancer;Gerber;JAMA,1996

4. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer;D'Amico;J Clin Oncol,1999

5. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer;Kattan;J Natl Cancer Inst,1998

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early prediction of prostate cancer biochemical recurrence and identification of disease persistence using PSA isoforms and human kallikrein-2;Tumor Biology;2021-08-24

2. Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high‐risk men;The Prostate;2019-10-11

3. Targeting strategies of adenovirus-mediated gene therapy and virotherapy for prostate cancer;Molecular Medicine Reports;2017-05

4. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer;Urologic Oncology: Seminars and Original Investigations;2016-05

5. A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer;Sensors;2015-05-22